Web Results

www.shb.com/news/2016/03/aventis-clomid-defeats-claims

Mar 23, 2016 ... Plaintiff Victoria Cerveny allegedly took Clomid in September and October 1992. Shortly ... The case name is Cerveny et al v. Sanofi et al.

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2014cv01317/55946/389

Jan 3, 2017 ... Amgen Inc. et al v. Sanofi et al, No. 1:2014cv01317 - Document 389 (D. Del. 2017) case opinion from the District of Delaware U.S. Federal ...

www.law360.com/cases/544125abb5ffec1e3b000003

Parties, docket activity and news coverage of federal case Amgen Inc. et al v. Sanofi et al, case number 1:14-cv-01317, from Delaware Court.

link.springer.com/article/10.1007/s10875-016-0265-6

Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of ... Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, et al.

clincancerres.aacrjournals.org/content/clincanres/early/2013/10/16/1078-0432.CCR-13-0580.full.pdf

sanofi ; Laurence Hatteville sanofi , Samira Ziti-Ljajic sanofi , Anne Caron sanofi ( C) Consultant .... assessment of adverse events using the NCICTC AE vs 3.0. ..... Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, et al.

mct.aacrjournals.org/content/early/2017/03/08/1535-7163.MCT-16-0688.full-text.pdf

Mar 3, 2017 ... breast cancer (18), and the discontinuation of Sanofi's SAR3419 in diffuse large ...... Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, et al. ... de Guibert S, Dupuis J, Ribrag V, Bouabdallah R, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3646316

Mar 26, 2012 ... Diehl V, Franklin J, Pfreundschuh M, et al. ... Sutherland MS, Sanderson RJ, Gordon KA, et al. ... Francisco JA, Cerveny CG, Meyer DL, et al.

www.sciencedirect.com/science/article/pii/S073497501530001X

Behrens and Liu (2014) and Panowksi et al. ... Sanofi-Genzyme, Glycoengineering .... The importance of conjugation site was also described by Strop et al.

www.mdpi.com/2073-4468/2/1/113/pdf

Feb 27, 2013 ... CD19. Hz IgG1 SPDB. Maytansine DM4 Phase II NHL sanofi. BT062. CD138 ..... Doronina, S.O.; Toki, B.E.; Torgov, M.Y.; Mendelsohn, B.A.; Cerveny, C.G.; Chace, D.F.;. DeBlanc, R.L.; Gearing, R.P.; Bovee, T.D.; Siegall, C.B.; et al. .... Kovtun, Y.V.; Goldmacher, V.S. Cell killing by antibody-drug conjugates.